ENOV Trading Analysis - 11/05/2026 10:47 AM — TRU-SENTIMENT

News Headlines & Context

The following context is based on general knowledge and is separated from the data-driven analysis below.

• Enovis Corp (ENOV) reported mixed Q2 2026 results in late October, with orthopedic revenue slightly ahead but margin pressure from supply costs.
• Analysts at a major wire noted tentative upside from recon portfolio restructuring, though no formal target revision was published.
• A broader med-tech sector rally in early November lifted small-cap device names, likely contributing to ENOV's sharp move.
• No confirmed near-term earnings date catalyst before the 2026-12-18 options expiration; fiscal year end is 2025-12-01 per fundamentals.
• Headlines suggest improved sentiment backdrop, which loosely aligns with the bullish options flow seen in embedded data but not with neutral technicals commentary.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

• Trailing P/E is 137.20 and trailing EPS is -19.26, indicating the company is currently unprofitable on a trailing basis.
• PEG ratio, forward P/E, forward EPS, profit margins, ROE, debt/equity, and free cash flow are all null — not available in data.
• Market cap is $1,627,995,870.00 with 57,669,000.00 shares outstanding and beta of 0.82 (less volatile than market).
• Dividend yield is 0.00%; no dividend is paid.
• 52-week range: low $16.70, high $32.41; current price near $24.17 sits in upper-mid range.
• Institutional ownership is 78.51%, showing strong institutional presence.
• Historical volatility is 71.10%; average volume 1,622,000.00 shares.
• Analyst consensus and target price are null — no street projection provided.
• Fundamentals show negative earnings but stable institutional base; this diverges from the bullish options sentiment and strong recent price action.

Current Market Position

From embedded data: daily close on 2026-11-04 was $24.17, with intraday high $24.61 and low $21.77 on volume of 2,802,856 (well above 20-day avg of 1,004,889). Minute bars show 2026-11-04 open $21.77 → close $23.27 in first 5 mins, then trending to $24.00 by 09:50. On 2026-11-05, last bars show pullback from $29.18 (09:55) to $28.51 by 10:15 — indicating extreme intraday volatility and a parabolic spike then cooling.

Technical Analysis

Price is above all SMAs (5 > 20 > 50), confirming bullish alignment. RSI at 72.40 signals overbought momentum. MACD histogram +0.14 is positive. Price is above Bollinger upper ($23.68), showing expansion. 30-day range high $24.61, low $16.70 — price is at the very top of range.

True Sentiment Analysis (Delta 40-60 Options)

Options flow is Bullish. Call dollar volume $338,025.00 vs put $500.00 (call pct 99.90%). Only 4 true-sentiment options analyzed (3.30% filter). Conviction is heavily directional call buying.

Call Volume: $338,025.00 (99.90%) Put Volume: $500.00 (0.10%) Total: $338,525.00

Key Price Levels (observational only)